Suspension of trading
Sector Adaptimmune Therapeutics plc Börse Stuttgart
Stocks
473A
US00653A1079
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0100 EUR | -.--% |
|
-41.18% | -9.09% |
| 05-18 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 11-17 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.76% | +2.09% | +8.40% | -13.01% | -13.46% | +20.88% | -3.54% | +15.08% | +76.54% | 67.44B | |
| +0.52% | -5.52% | -4.69% | -8.02% | +4.78% | +46.80% | +219.12% | +176.85% | +269.06% | 53.98B | |
| -2.79% | +32.50% | +32.50% | +32.50% | +32.50% | +32.50% | +32.50% | +32.50% | - | 41.77B | |
| -2.20% | +0.79% | +19.25% | -11.80% | -28.89% | -49.35% | -53.52% | -56.01% | +9.61% | 41.15B | |
| -0.72% | -7.96% | -0.10% | +12.31% | +13.02% | +49.53% | -27.69% | -44.46% | -20.85% | 29.58B | |
| +3.74% | -4.01% | +60.40% | +49.30% | +159.61% | +133.49% | -35.59% | -67.11% | - | 29.28B | |
| +1.07% | +1.42% | +14.81% | +22.24% | +20.00% | +72.47% | +90.95% | +44.47% | +38.30% | 23.43B | |
| +2.66% | +1.08% | +19.37% | +0.28% | +16.39% | +10.59% | +198.32% | +1.84% | - | 19.11B | |
| +1.14% | -0.17% | +9.87% | +19.10% | +43.87% | +68.83% | +135.40% | +195.28% | +344.16% | 16.82B | |
| +15.12% | +16.82% | +33.23% | +19.40% | +17.88% | +96.11% | +433.87% | +40.52% | - | 15.36B | |
| +1.38% | +1.90% | +1.35% | +39.16% | +36.31% | +121.58% | +242.43% | +281.12% | +3,145.76% | 12.64B | |
| +0.37% | +1.66% | +3.56% | +6.52% | +0.91% | +0.50% | -29.51% | -28.28% | -34.45% | 11.55B | |
| -4.31% | -14.65% | -8.12% | -18.92% | -33.26% | -29.16% | +677.20% | +285.85% | +4,865.52% | 11.12B | |
| -1.11% | -1.02% | +19.85% | +43.71% | +50.58% | +149.32% | +207.70% | +438.97% | - | 11.07B | |
| +1.96% | -13.66% | +35.65% | -9.79% | +24.33% | +37.16% | +333.64% | +283.76% | - | 6.6B | |
| -0.09% | -1.30% | +0.69% | +1.26% | -15.96% | -20.85% | -26.63% | -58.52% | -55.37% | 6.19B | |
| +0.53% | -12.38% | +3.94% | -25.39% | -29.16% | -29.80% | +138.58% | +105.64% | +113.86% | 5.65B | |
| +4.80% | -5.61% | +33.70% | +91.79% | +195.30% | +139.44% | +380.36% | -27.00% | - | 5.57B | |
| -0.18% | +9.59% | +12.20% | -1.46% | -7.83% | +14.07% | +66.07% | -35.17% | - | 5.5B | |
| Average | +1.21% | -1.28% | +15.57% | +13.11% | +25.63% | +45.48% | +156.82% | +83.44% | +795.65% | 21.78B | |
| Weighted average by Cap. | +0.71% | -1.12% | +15.29% | +8.85% | +19.27% | +40.70% | +100.52% | +58.83% | +428.89% |
- Stock Market
- Stocks
- ADAPY Stock
- 473A Stock
- Sector Adaptimmune Therapeutics plc
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
